Sign In
Buy BNTX
$89.59
+1.14 (+1.29%)
At Close: Jun 04, 2026
2 Monster Stocks to Buy Without Any Hesitation
03:37pm, Thursday, 21'st Apr 2022 The Motley Fool
These healthcare giants know something about beating the market.
Moderna (MRNA) Posts Upbeat Data on Bivalent COVID Booster Jab
02:02pm, Wednesday, 20'th Apr 2022 Zacks Investment Research
Moderna's (MRNA) bivalent COVID booster candidate creates superior neutralizing antibodies compared to its currently authorized COVID vaccine mRNA-1273's booster dose against all variants of concern.
Moderna is developing a COVID-19 booster that protects against omicron and the original virus
12:05pm, Wednesday, 20'th Apr 2022 MarketWatch
The company said it expects to have clinical data for this shot by the end of June.
3 Top Biotech Stocks Ready for a Bull Run
11:40am, Wednesday, 20'th Apr 2022 The Motley Fool
The hype has died down. Now it's time for science to take over.
3 Top Biotech Stocks Ready for a Bull Run
07:40am, Wednesday, 20'th Apr 2022
The hype has died down. Now it's time for science to take over.
BioNTech SE Sponsored ADR (BNTX) Gains But Lags Market: What You Should Know
10:00pm, Tuesday, 19'th Apr 2022 Zacks Investment Research
BioNTech SE Sponsored ADR (BNTX) closed the most recent trading day at $159.74, moving +0.11% from the previous trading session.
Why Ocugen Stock Tumbled by Nearly 6% Today
11:25pm, Monday, 18'th Apr 2022 The Motley Fool
Investors were probably concerned the expansion of a licensing deal was pricey.
Pfizer (PFE), BioNTech (BNTX) COVID Booster Effective in Young Kids
06:27pm, Monday, 18'th Apr 2022 Zacks Investment Research
A third dose of Pfizer (PFE) and partner BioNTech's (BNTX) COVID-19 vaccine achieves a significant immune response against the Omicron variant in children aged between 5 years and 11 years.
Why BioNTech, Moderna, and Novavax Stocks Are Sinking Today
05:39pm, Monday, 18'th Apr 2022 The Motley Fool
Each vaccine stock is moving lower for a different reason.
Pfizer (PFE), BioNTech (BNTX) COVID Booster Effective in Young Kids
03:48pm, Monday, 18'th Apr 2022
A third dose of Pfizer (PFE) and partner BioNTech's (BNTX) COVID-19 vaccine achieves a significant immune response against the Omicron variant in children aged between 5 years and 11 years.
Why BioNTech, Moderna, and Novavax Stocks Are Sinking Today
01:39pm, Monday, 18'th Apr 2022
Each vaccine stock is moving lower for a different reason.
Pfizer/BioNTech Fourth COVID-19 Vaccine Dose Protects Against Omicron For At Least One Month
12:27pm, Monday, 18'th Apr 2022
A fourth dose of the COVID-19 vaccine from Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) provided significant protection against severe disease, hospitalization, and death for at least a m
Novavax (NVAX) COVID Jab Gets Nod for Use in Switzerland
07:27pm, Thursday, 14'th Apr 2022 Zacks Investment Research
Novavax's (NVAX) Nuvaxovid is the first protein COVID-19 vaccine authorized for use in Switzerland. The stock price rises following the announcement.
New York State's recent COVID case surge caused by two new versions of omicron that are even more infectious than BA.2
05:35pm, Thursday, 14'th Apr 2022 MarketWatch
A surge of COVID-19 cases in New York State that is making it once again an epicenter of the U.S. pandemic is due to two new versions of the omicron variant, that appear even more infectious than the
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Pfizer-BioNTech's COVID-19 Vaccine Booster Shows High Immune Response In Kids Ages 5-11
Pfizer Inc (
